Preview

Clinical Medicine (Russian Journal)

Advanced search

Post-COVID-19 syndrome

https://doi.org/10.30629/0023-2149-2021-99-7-8-429-435

Abstract

The disease caused by new coronavirus infection (COVID-19) is a global problem not only because of its wide spread occurrance, but also due to the high incidence of post-COVID syndrome. The literature review presents the results of numerous observations of patients, who undergone COVID-19. The most common symptoms are: general weakness, impaired cognitive functions, memory loss, depression, anosmia, dysgeusia, shortness of breath, cough, chest pain, abdominal pain, anorexia, nausea, vomiting, diarrhea, less often — alopecia, skin rashes, etc. The most frequent symptoms of the post-COVID syndrome are described; the reasons and risk factors for its development are analyzed. The lack of views sameness on the term “postCOVID syndrome” makes it diffi cult to evaluate the frequency of certain symptoms development. Variants of the post-COVID syndrome are considered. It is proposed to distinguish between the post-COVID syndrome, developed after acute COVID-19 that lasts up to 12 weeks, and a prolonged variant of post-COVID clinical symptoms that last longer than 12 weeks, which should be distinguished from lingering COVID-19, its complications, and the consequences of intensive care. The questions of prognosis, diagnostics, and treatment of post-COVID syndrome are discussed.

About the Author

N. S. Asfandiyarova
Ryazan State Medical University
Russian Federation

Nailya S. Asfandiyarova

390026, Ryazan



References

1. Klitzman R.L. Needs to Prepare for «Post-COVID-19 Syndrome». Am. J. Bioeth. 2020;20(11):4–6. Available from: https://doi.org/10.1 080/15265161.2020.1820755

2. Amenta E.M., Spallone A., Rodriguez-Barradas M.C., El Sahly H.M., Atmar R.L., Kulkarni P.A. Post-acute COVID-19: an overview and approach to classifi cation. Open Forum Infect. Dis. [Internet] 2020. [cited 2020 Dec 13]; Available from: https://www.ncbi. nlm.nih.gov/pmc/articles/PMC7665635/

3. Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M. et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2020; Dec. 3 [Epub ahead of print]. Available from: https://thorax.bmj.com/content/early/2020/12/02/ thoraxjnl-2020-216086

4. Chopra V., Flanders S.A., O’Malley M., Malani A.N., Prescott H.C. Sixty-day outcomes among patients hospitalized with COVID-19. Ann. Intern. Med. 2020; Nov. 11 [Epub ahead of print]. Available from: https://www.acpjournals.org/doi/10.7326/M20-5661

5. Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L. et al. Post discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J. Med. Virol. 2020; First published: 30 July 2020. Available from: https://doi. org/10.1002/jmv.26368

6. Moreno-Pérez O., Merino E., Leon-Ramirez J.-M., Andres M., Ramos J.M., Arenas-Jiménez J. et al. Post-acute COVID-19 Syndrome incidence and risk factors: a Mediterranean cohort study. J. Infect. 2021;82(3):378–383. DOI: 10.1016/j.jinf.2021.01.004

7. Willi S., Lüthold R Hunt A Hänggi N.V., Sejdiu D., Scaff C., Bender N. et al. COVID-19 sequelae in adults aged less than 50 years: a systematic review. Travel Med. Infect. Dis. 2021;40:101995. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC7898978/

8. Carfì A., Bernabei R., Landi F. Gemelli against COVID-19 postacute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603–605 Available from: https://jamanetwork.com/journals/jama/fullarticle/2768351

9. Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufi ls E., Bourbao-Tournois C., Laribi S. et al. Follow-up of adults with noncriti cal COVID-19 two months after symptoms’ onset. Follow-up of adults with non-critical COVID-19 two months after symptoms’ onset. Clin.Microbiol. Infect. 2021;27(2):258–263. DOI: 10.1016/j. cmi.2020.09.052

10. Tenforde M.W., Kim S.S., Lindsell C.J., Rose E.B., Shapiro N.I., Files C. et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network: United States, March-June 2020. Morb. Mortal Wkly. Rep. 2020;69(30):993–998. Available from: https:// www.cdc.gov/mmwr/volumes/69/wr/mm6930e1.htm

11. Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGro der C., Stevens J.S. et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601–615. Available from: https://doi.org/10.1038/s41591- 021-01283-z

12. Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H. et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81(6):E4–E6.

13. Huang C., Huang L., Wang Y., Li X., Ren L., Gu X. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Huang, January 2021). Lancet. 2021;397:220–232.

14. Ayoubkhani D., Khunti K., Nafi lyan V., Maddox T., Humberstone B., Sir Diamond I., Banerjee A. Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. MedRxiv: the Preprint Server for Health Sciences. 2021.01.15.21249885. DOI: 10.1101/2021.01.15.21249885. Now accepted for publication in BMJ.

15. Sudre C.H., Murray B., Varsavsky T., Graham M.S., Bowyeк R.C., Pujol J.C. et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626–631. Available from: https://doi.org/10.1038/s41591- 021-01292-y

16. Vanichkachorn G., Newcomb R., Cowl C.T., Murad MH., Breeher L., Miller S. et al. Post COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at the Mayo Clinic and Characteristics of the Initial Patient Cohort. Mayo Clinic Proceedings. 2021. DOI: 10.1016/j.mayocp.2021.04.024.

17. Pavli A., Theodoridou M., Maltezou H.C. Post-COVID syndrome: Incidence, clinical spectrum., and challenges for primary healthcare professionals. Arch. Med. Res. 2021. Available from: https://doi. org/10.1016/j.arcmed.2021.03.010

18. Greenhalgh T., Knight M., A’Court С., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. DOI: 10.1136/ bmj.m3026.

19. National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term eff ects of COVID-19. 2020. Available from: https://www.nice.org.uk/guidance/ng188

20. Maltezou H.C., Pavli A., Tsakris. A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines. 2021;9:497. Avaliable from: https://doi.org/10.3390/vaccines9050497

21. COVID-19 rapid guideline: managing the long-term eff ects of COVID-19. NICE guideline [NG188]. Published date: 18 December 2020 Available from: https://www.nice.org.uk/guidance/ NG188?utm_source

22. Augustin M., Schommers Ph., Stecher M., Dewald F., Gieselmann L., Gruell H.et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. The Lancet Regional Health – Europe 6. 2021:100122 Science Direct. Available from: http://creativecommons.org/licenses/by-nc-nd/4.0/

23. Azer S.A. COVID-19: pathophysiology., diagnosis., complications and investigationaltherapeutics. New Microbes. New Infect. 2020;37:100738. DOI: 10.1016/j.nmni.2020.100738. PMID: 32834902; PMCID: PMC7403867.

24. COVID-19: Clinical management. WHO. 25.01.2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-1

25. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Temporary methodological recommendations. Version 11 (07.05.2021). Ministry of Health of the Russian Federation (in Russian). ttps://edu-rosminzdrav.ru.com/ profi laktika-diagnostika-i-lechenie-covid-19/

26. Kozlov I.А., Tyurin I.N. Cardiovascular complications of COVID-19. Messenger of Anesthesiology and Resuscitation.2020;17(4):14–22. (in Russian). DOI: 10.21292/2078-5658- 2020-17-4-14-22.

27. Smirnova E.A., Sedykh E.V. Acute decompensation of heart failure: current issues of epidemiology, diagnostics, therapy. Science of the young (Eruditio Juvenium). 2021;9(2):289– 300. (in Russian). DOI:10.23888/HMJ202192289-300.

28. Aghagoli G., Gallo Marin B., Soliman LB., Sellke F.W. Cardiac involvement in COVID-19 patients: Risk factors., predictors., and complications: A review. J. Card. Surg. 2020;35:1302–1305.

29. Chen C., Zhou Y., Wang D.W. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;45(3):230–232. DOI:10.1007/s00059-020-04909-z

30. Kochi A.N., Tagliari A.P., Forleo G.B.Fassini G.M., Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J. Cardiovasc. Electrophysiol. 2020;31(5):1003–1008. DOI: 10.1111/ jce.14479

31. Kunutsor S.K., Laukkanen J.A. Cardiovascular complications in COVID-19: A systematic review and meta-analysis. J. Infect. 2020;81(2):e139–e141. DOI: 10.1016/j.jinf.2020.05.068. Epub 2020 Jun 3. PMID: 32504747; PMCID: PMC7832225

32. Long B., Brady W.J., Koyfman A., Gotleb M. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 2020;38(7);1504– 1507. DOI: 10.1016/j.ajem.2020.04.048

33. Zhu H., Rhee J-W., Cheng P., Waliany S., Chang A., Witteles R.M. et al. Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response. Curr. Cardiol. Rep. 2020;22(5):32. DOI: 10.1007/s11886-020-01292-3

34. Belopasov V.V., Yachou Y., Samoilova E.M., Baklaushev V.P. The Nervous System Damage in COVID-19. J. Clin. Practice. 2020;11(2):60–80. (in Russian). DOI: 10.17816/clinpract34851

35. Ternovyh I.K., Topuzova M.P., Chaykovskaya A.D., Isabekova P.S., Alekseeva T.M. Neurological manifestations and complications in patients with COVID-19. Translational Medicine. 2020;7(3):21–29. (in Russian). Available from: https:// doi.org/10.18705/2311-4495-2020-7-3-21-29

36. Maiti T., Essam L., Orsolini L., Ramalho R., El Halabi S., Nguyen V. et al. COVID-19-induced psychoses: new chal lenges for aspiring psychiatric careers. IP Pavlov Russian Medical Biological Herald. 2021;29(2):325-331. (in Russian). Available from: https: //journals.eco-vector.com/pavlovj/index

37. Li G., Yang Y., Gao D., XuY., GuJ., Liu P. Is liver involvement overestimated in COVID-19 patients? A meta-analysis. Int. J. Med Sci. 2021;18(5):1285–1296. Available from: https://www.medsci.org/ v18p1285.htm

38. Wang F., Wang H., Fan J., Zhang Y., Wang H., Zhao Q. Pancreatic injury patterns in patients with COVID-19 pneumonia. Gastroenterology. 2020;159(1):367–370. Available from: https://www.ncbi. nlm.nih.gov/pmc/articles/PMC7118654/

39. Kirkey S. It’s only ‘the end of the beginning.’ COVID-19 will be with us for years. NATIONAL POST. Feb 16 2021. Available from: https://nationalpost.com/news/postpandemic/its-only-the-end-ofthe-beginning-of-covid-19


Review

For citations:


Asfandiyarova N.S. Post-COVID-19 syndrome. Clinical Medicine (Russian Journal). 2021;99(7-8):429-435. (In Russ.) https://doi.org/10.30629/0023-2149-2021-99-7-8-429-435

Views: 1282


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0023-2149 (Print)
ISSN 2412-1339 (Online)